What predicts death in the ICU? Analyzing APACHE II in Colombian patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a single-center, retrospective cohort study at Hospital Departamental de Villavicencio. Researchers collected data on adult ICU patients admitted between January 2022 and June 2025, calculating APACHE II scores at admission and tracking outcomes to compare mortality by disease type and admission source. They aim to determine which factors are associated with death in the ICU and to validate how accurately APACHE II predicts mortality in this population. The study uses consecutive cases from the ICU discharge database, excluding intermediate-care admissions and transfers to other facilities. Findings could inform local prognostic use of APACHE II and help tailor critical care planning in this setting.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* All adult patients older than 18 admitted to the intensive care unit during the study period.

Exclusion Criteria:

* Patients admitted for intermediate care (low therapeutic intervention with a TISS \[Therapeutic Intervention Scoring System\] - 28 score below 20 points). Patients derived to other institutions.

Where it's running

• Hospital Departamental de Villavicencio
  Villavicencio, Meta Department, Colombia Recruiting

Study contacts

• Principal investigator: Norton Perez Gutierrez, MD — Hospital Departamental de Villavicencio
• Study coordinator: Norton Perez Gutierrez, MD
• Email: norton.perez@hotmail.com
• Phone: 3112517471

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Muscle Mass and Blood Gases in ICU Patients

  This study tests whether muscle mass in adults in the ICU is related to oxygen levels and other blood gas and vital signs.

  Recruiting Ankara Yildirim Beyazıt University · Erzurum · NCT07866625

• Permissive lung-protective ventilation in invasively ventilated adults

  This study tests whether lowering the breathing rate during mechanical ventilation is better than standard lung-protective ventilation for adults in the ICU who need invasive ventilation.

  Recruiting Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · Amsterdam, NL and 1 other locations · NCT07837128

• Testing an ICU time-series model to predict mortality at a major hospital

  We will see if a pre-trained time-series model can accurately forecast outcomes for ICU patients using real-world data.

  Recruiting Peking University People's Hospital · Beijing, Beijing Municipality · NCT07795450

• Can blood and physical tests before transplant predict non-relapse mortality

  This study tests whether pre-transplant blood markers and physical tests can predict non-relapse mortality in adults undergoing stem cell therapy.

  Recruiting Henry Ford Health System · Detroit, Michigan · NCT07769151

• Gut microbes and blood signals in sepsis-related liver and kidney injury

  This study tests whether gut microbes and blood markers differ in adults with sepsis who develop liver or kidney injury, compared with healthy volunteers.

  Recruiting at 6 sites First Affiliated Hospital of Zhejiang University · Hangzhou, Zhejiang and 5 other locations · NCT07735182

• Prediction score for death or lung transplant in emphysema caused by alpha-1 antitrypsin deficiency

  This study tests a new prediction tool to identify people with emphysema due to alpha-1-antitrypsin deficiency who are at high risk of death or needing a lung transplant.

  Recruiting at 4 sites University Hospital, Bordeaux · Bron and 3 other locations · NCT07715617

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.